Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
To the Editor The Viewpoint by Dr Steinhubl and colleagues1 on mHealth and health care outlined the concerns about potentially dangerous mHealth apps that are proliferating, ostensibly because of the “unbridled enthusiasm” of the technology development community and consumers. Steinhubl et al1 alluded to difficulties in oversight of health care devices by the US Food and Drug Administration, which may be overwhelmed with the sheer number of apps and devices being developed and in effective use by clinicians and patients.2 One suggestion might be for researchers and the National Institutes of Health to consider additional funding mechanisms to rigorously test these apps and devices within scientifically measured patient outcomes.
Freeman WD. Implementation of Mobile Health Tools. JAMA. 2014;311(14):1448. doi:10.1001/jama.2014.1109